2015 VAM: 3301 - Entering the Yellow Zone: Management of Early Loss of Asthma Control
This recording reviews and highlights key findings of the Yellow Zone Practice Parameter. The information presented during this session will represent the most up to date asthma management guidelines in publication. New recommendations included within these practice parameters reflect a significant change in asthma management in some regards and a discussion of the expanding evidence regarding these new management strategies. It will also address the evidence surrounding recommendations to consider increasing the dose of maintenance inhaled corticosteroids during loss of control.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by June 30, 2017. Any credit request on or after July 1, 2017 will be subject to an administrative fee.
System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox
Alled Health Professionals
Upon completion of this activity, participants will be able to:
1. Discuss the acute loss of asthma control
2. Describe new recommendations for escalation of therapy highlighted within the Yellow Zone Practice Parameter
3. Discuss the evidence and indications for consideration of on-demand therapy with inhaled corticosteroids and inhaled corticosteroid/long acting beta agonist combination agents
Dr. John Oppenheimer, MD FAAAAI, Rutgers-NJ Med School, Denville, NJ
Dr. Chitra Dinakar, MD FAAAAI, Children's Mercy Hospital, Kansas City, MO
Dr. Leonard B. Bacharier, MD FAAAAI, Washington University School of Medicine, St. Louis, MO
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.